EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Substantiation of a clopidogrel metabolism-associated gene (CYP2C19) variation among healthy individuals

Anshu Kumar Yadav, Aparna Kodakkat Chakkumkollath, Aysha Helna, Siddharth Birla, Rajesh Kumar Thimmulappa, Sunil Kumar Shambu, Prashant Vishwanath, Akila Prashant

Indian Heart Journal · 2023

DOI: 10.1016/j.ihj.2023.05.005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Indian Heart Journal, 2023. Verfasst von Anshu Kumar Yadav und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center of Excellence in Molecular Biology and Regenerative Medicine, Department of Biochemistry, JSS Medical College, JSS Academy of Higher Education…. Hauptthemen laut MEDLINE: Aryl Hydrocarbon Hydroxylases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: JSS Academy of Higher Education and Research, Department of Biotechnology, Ministry of Science and Technology, India, Ministry of Science and Technology, Pakistan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: It is essential to investigate the prevalence of CYP2C19 alleles that affect drug metabolism. This study measures the allelic and genotypic frequencies of CYP2C19 loss-of-function (LoF) alleles CYP2C19∗2, CYP2C19∗3, and gain-of-function (GoF) alleles CYP2C19∗17 in the general population. METHODOLOGY: The study involved 300 healthy subjects between the ages of 18 and 85 recruited by simple random sampling. Allele-specific touchdown PCR was employed to identify the various alleles. The genotype and allele frequencies were calculated and checked for Hardy-Weinberg equilibrium. The phenotypic prediction of ultra-rapid metabolizer (UM = ∗17/∗17), extensive metabolizer (EM = ∗1/∗17, ∗1/∗1), intermediate metabolizer (IM = ∗1/∗2, ∗1/∗3, ∗2/∗17) and poor metabolizer (PM = ∗2/∗2, ∗2/∗3, ∗3/∗3) was made based on their genotype. RESULTS: The allele frequency of CYP2C19∗2, CYP2C19∗3, and CYP2C19∗17 was 0.365, 0.0033, and 0.18, respectively. The IM phenotype predominated with an overall frequency of 46.67%, including 101 subjects with ∗1/∗2, two subjects with ∗1/∗3, and 37 subjects with ∗2/∗17 genotype. This was followed by EM phenotype with an overall frequency of 35%, including 35 subjects with ∗1/∗17 and 70 subjects with ∗1/∗1 genotype. PM phenotype had an overall frequency of 12.67%, including 38 subjects with ∗2/∗2 genotype, and UM phenotype had an overall frequency of 5.67%, including 17 subjects with ∗17/∗17 genotype. CONCLUSION: Given the high allelic frequency of PM in the study population, a pre-treatment test to identify the individual's genotype may be recommended to decide the dosage, monitor the drug response, and avoid adverse drug reactions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aryl Hydrocarbon HydroxylasesHumansAdolescentYoung AdultAdultMiddle AgedAgedAged, 80 and overClopidogrelCytochrome P-450 CYP2C19Gene FrequencyGenotypeAllelesPlatelet Aggregation Inhibitors

Stichwörter der Autor:innen

Adverse drug eventsCYP2C19ClopidogrelHumanPharmacogenomics

Substanzen

ClopidogrelAryl Hydrocarbon HydroxylasesCytochrome P-450 CYP2C19Platelet Aggregation InhibitorsCYP2C19 protein, human

Autor:innen und Institutionen

  • Center of Excellence in Molecular Biology and Regenerative Medicine, Department of Biochemistry, JSS Medical College, JSS Academy of Higher Education & Research, Mysuru, India.
  • Department of Cardiology, JSS Medical College, JSS Academy of Higher Education & Research, Mysuru, India.
  • Center of Excellence in Molecular Biology and Regenerative Medicine, Department of Biochemistry, JSS Medical College, JSS Academy of Higher Education & Research, Mysuru, India; Special Interest Group - Human Genomics an…

Förderung

  • JSS Academy of Higher Education and Research
  • Department of Biotechnology, Ministry of Science and Technology, India
  • Ministry of Science and Technology, Pakistan
  • Department of Science and Technology, Ministry of Science and Technology, India

Zitieren

APA

Yadav, A. K., Chakkumkollath, A. K., Helna, A., Birla, S., Thimmulappa, R. K., Shambu, S. K., Vishwanath, P., & Prashant, A. (2023). Substantiation of a clopidogrel metabolism-associated gene (CYP2C19) variation among healthy individuals. Indian Heart Journal. https://doi.org/10.1016/j.ihj.2023.05.005

Vancouver

Yadav AK, Chakkumkollath AK, Helna A, Birla S, Thimmulappa RK, Shambu SK, et al. Substantiation of a clopidogrel metabolism-associated gene (CYP2C19) variation among healthy individuals. Indian Heart Journal. 2023. doi:10.1016/j.ihj.2023.05.005

BibTeX
@article{Yadav2023,
  author = {Yadav, Anshu Kumar and Chakkumkollath, Aparna Kodakkat and Helna, Aysha and Birla, Siddharth and Thimmulappa, Rajesh Kumar and Shambu, Sunil Kumar and Vishwanath, Prashant and Prashant, Akila},
  title = {Substantiation of a clopidogrel metabolism-associated gene (CYP2C19) variation among healthy individuals},
  journal = {Indian Heart Journal},
  year = {2023},
  doi = {10.1016/j.ihj.2023.05.005}
}
Kostenlos starten →